A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia

Clinical trial NCT07086976 · RECRUITING

Trial details

NCT number: NCT07086976
Sponsor: Sanofi
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Autoimmune Haemolytic Anaemia

Start date: 2025-08-18
Primary completion: 2028-05-31
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.